MK2206 inhibits hepatocellular carcinoma cellular proliferation via induction of apoptosis and cell cycle arrest

Autor: Wilson, J.M., Kunnimalaiyaan, S., Gamblin, T.C., Kunnimalaiyaan, M.

Publikováno v: In Journal of Surgical Research October 2014 191(2):280-285

MRE11-dependent instability in mitochondrial DNA fork protection activates a cGAS immune signaling pathway.

Autor: Luzwick JW; Department of Cancer Biology, UT MD Anderson Cancer Center, Houston, TX, USA., Dombi E; Department of Cancer Biology, UT MD Anderson Cancer Center, Houston, TX, USA., Boisvert RA; Department of Cancer Biology, UT MD Anderson Cancer Center, Houston, TX, USA., Roy S; Department of Cancer Biology, UT MD Anderson Cancer Center, Houston, TX, USA., Park S; Department of Cancer Biology, UT MD Anderson Cancer Center, Houston, TX, USA., Kunnimalaiyaan S; Department of Cancer Biology, UT MD Anderson Cancer Center, Houston, TX, USA., Goffart S; Department of Environmental and Biological Sciences, University of Eastern Finland, Joensuu, Finland., Schindler D; Institut für Humangenetik, University of Würzburg, Würzburg, Germany., Schlacher K; Department of Cancer Biology, UT MD Anderson Cancer Center, Houston, TX, USA.

Publikováno v: Science advances [Sci Adv] 2021 Dec 17; Vol. 7 (51), pp. eabf9441. Date of Electronic Publication: 2021 Dec 15.

Synergistic Proliferation Effects of Xanthohumol and Niflumic Acid on Merkel and Glioblastoma Cancer Cells: Role of Cell Membrane Interactions.

Autor: Stompor-Gorący, Monika¹ (AUTHOR) mstompor@ur.edu.pl, Włoch, Aleksandra² (AUTHOR) aleksandra.wloch@upwr.edu.pl, Sengupta, Priti² (AUTHOR) pritisengupta1@gmail.com, Nasulewicz-Goldeman, Anna³ (AUTHOR) anna.nasulewicz-goldeman@hirszfeld.pl, Wietrzyk, Joanna³ (AUTHOR) joanna.wietrzyk@hirszfeld.pl

Publikováno v: International Journal of Molecular Sciences. Oct2024, Vol. 25 Issue 20, p11015. 15p.

Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary Carcinoma.

Autor: Msaouel P; Department of Genitourinary Medical Oncology, Unit 1374, The University of Texas MD Anderson Cancer Center, 1155 Pressler Street, Houston, TX 77030-3721, USA; Center for Precision Environmental Health, Baylor College of Medicine, Houston, Texas, USA. Electronic address: pmsaouel@mdanderson.org., Malouf GG; Department of Hematology and Oncology, Strasbourg University Hospitals, Strasbourg University, Strasbourg, France; Department of Functional Genomics and Cancer, Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS/INSERM/UNISTRA, Illkirch Cedex, France., Su X; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Yao H; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Tripathi DN; Center for Precision Environmental Health, Baylor College of Medicine, Houston, Texas, USA., Soeung M; Department of Genomic Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA., Gao J; Department of Genitourinary Medical Oncology, Unit 1374, The University of Texas MD Anderson Cancer Center, 1155 Pressler Street, Houston, TX 77030-3721, USA., Rao P; Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA., Coarfa C; Department of Medicine and Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA., Creighton CJ; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Medicine and Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA., Bertocchio JP; Department of Genitourinary Medical Oncology, Unit 1374, The University of Texas MD Anderson Cancer Center, 1155 Pressler Street, Houston, TX 77030-3721, USA; Center for Precision Environmental Health, Baylor College of Medicine, Houston, Texas, USA., Kunnimalaiyaan S; Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Multani AS; Department of Genetics, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA., Blando J; Department of Immunology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA., He R; Department of Genitourinary Medical Oncology, Unit 1374, The University of Texas MD Anderson Cancer Center, 1155 Pressler Street, Houston, TX 77030-3721, USA., Shapiro DD; Department of Urology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA., Perelli L; Department of Genitourinary Medical Oncology, Unit 1374, The University of Texas MD Anderson Cancer Center, 1155 Pressler Street, Houston, TX 77030-3721, USA., Srinivasan S; Department of Genomic Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Carbone F; Department of Genitourinary Medical Oncology, Unit 1374, The University of Texas MD Anderson Cancer Center, 1155 Pressler Street, Houston, TX 77030-3721, USA., Pilié PG; Department of Genitourinary Medical Oncology, Unit 1374, The University of Texas MD Anderson Cancer Center, 1155 Pressler Street, Houston, TX 77030-3721, USA., Karki M; Center for Precision Environmental Health, Baylor College of Medicine, Houston, Texas, USA., Seervai RNH; Center for Precision Environmental Health, Baylor College of Medicine, Houston, Texas, USA; Molecular & Cellular Biology Graduate Program, Medical Scientist Training Program, Baylor College of Medicine, Houston, TX 77030, USA., Vokshi BH; Department of Hematology and Oncology, Strasbourg University Hospitals, Strasbourg University, Strasbourg, France; Department of Functional Genomics and Cancer, Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS/INSERM/UNISTRA, Illkirch Cedex, France., Lopez-Terrada D; Department of Pathology, Texas Children's Hospital, Houston, TX 77030, USA., Cheng EH; Human Oncology & Pathogenesis Program and Department of Pathology, Memorial Sloan Kettering Cancer Institute, New York City, NY 10065, USA., Tang X; Department of Translational Molecular Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA., Lu W; Department of Translational Molecular Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA., Wistuba II; Department of Translational Molecular Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA., Thompson TC; Department of Genitourinary Medical Oncology, Unit 1374, The University of Texas MD Anderson Cancer Center, 1155 Pressler Street, Houston, TX 77030-3721, USA., Davidson I; Department of Functional Genomics and Cancer, Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS/INSERM/UNISTRA, Illkirch Cedex, France., Giuliani V; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION), The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Schlacher K; Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Carugo A; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION), The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Heffernan TP; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION), The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Sharma P; Department of Genitourinary Medical Oncology, Unit 1374, The University of Texas MD Anderson Cancer Center, 1155 Pressler Street, Houston, TX 77030-3721, USA; Department of Immunology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA., Karam JA; Department of Urology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA; Department of Translational Molecular Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA., Wood CG; Department of Urology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA., Walker CL; Center for Precision Environmental Health, Baylor College of Medicine, Houston, Texas, USA; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA; Department of Medicine, Baylor College of Medicine, Houston, Texas, USA; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA. Electronic address: cheryl.walker@bcm.edu., Genovese G; Department of Genitourinary Medical Oncology, Unit 1374, The University of Texas MD Anderson Cancer Center, 1155 Pressler Street, Houston, TX 77030-3721, USA; Department of Genomic Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: ggenovese@mdanderson.org., Tannir NM; Department of Genitourinary Medical Oncology, Unit 1374, The University of Texas MD Anderson Cancer Center, 1155 Pressler Street, Houston, TX 77030-3721, USA. Electronic address: ntannir@mdanderson.org.

Publikováno v: Cancer cell [Cancer Cell] 2020 May 11; Vol. 37 (5), pp. 720-734.e13. Date of Electronic Publication: 2020 Apr 30.

Growth suppression by alteration in keap1/Nrf2-Notch-STAT3 signaling in cholangiocarcinoma

Autor: Kunnimalaiyaan, S., Gamblin, T.C., Kunnimalaiyaan, M.

Publikováno v: In HPB March 2018 20 Supplement 1:S5-S5